NZ223217A - Hiv-2 envelope peptides and compositions containing them - Google Patents

Hiv-2 envelope peptides and compositions containing them

Info

Publication number
NZ223217A
NZ223217A NZ22321788A NZ22321788A NZ223217A NZ 223217 A NZ223217 A NZ 223217A NZ 22321788 A NZ22321788 A NZ 22321788A NZ 22321788 A NZ22321788 A NZ 22321788A NZ 223217 A NZ223217 A NZ 223217A
Authority
NZ
New Zealand
Prior art keywords
hiv
compositions containing
envelope peptides
peptides
envelope
Prior art date
Application number
NZ22321788A
Other languages
English (en)
Inventor
Marc Alizon
Luc Montagnier
Denise Guetard
Francois Clavel
Pierre Sonigo
Mireille Guyader
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/003,764 external-priority patent/US5051496A/en
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of NZ223217A publication Critical patent/NZ223217A/xx

Links

NZ22321788A 1987-01-16 1988-01-18 Hiv-2 envelope peptides and compositions containing them NZ223217A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/003,764 US5051496A (en) 1986-01-22 1987-01-16 Peptides related to human immunodeficiency virus II (HIV-2)

Publications (1)

Publication Number Publication Date
NZ223217A true NZ223217A (en) 1990-08-28

Family

ID=21707471

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ22321788A NZ223217A (en) 1987-01-16 1988-01-18 Hiv-2 envelope peptides and compositions containing them

Country Status (4)

Country Link
IE (1) IE61711B1 (pt)
NZ (1) NZ223217A (pt)
PT (1) PT86565B (pt)
ZA (1) ZA88310B (pt)

Also Published As

Publication number Publication date
PT86565A (fr) 1988-02-01
PT86565B (pt) 1991-12-31
IE880115L (en) 1988-07-16
ZA88310B (en) 1988-07-22
IE61711B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
IL72799A0 (en) Peptides and pharmaceutical compositions containing them
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
IL72572A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IL85896A (en) Substituted di-tert.- butylphenols and pharmaceutical compositions containing them
IL86086A0 (en) Bifunctional proteins and pharmaceutical compositions containing them
GB2207922B (en) Tripeptides and pharmaceutical compositions containing them
NZ220441A (en) Unca-hydrazide-immunoglobulin (glyoprotein) conjugates and pharmaceutical composition
IL82146A0 (en) Liposomes based on phosphatidyl-inositolmannosides and pharmaceutical compositions containing them
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
AU6518486A (en) Peptides and compositions
IL86926A (en) Diphenyl-1h-pyrazole-1-alkanamides,their preparation and antiarrhythmic compositions containing them
NZ224393A (en) Recombinant hiv envelope proteins and uses thereof
PH19896A (en) 4-phenyl-tetrahydro-furano-pyridine and pharmaceutical compositions containing them
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
NZ219748A (en) Indenopyrimidines and pharmaceutical compositions
IL92650A0 (en) Polyhydroxybenzyloxypropanolamides and pharmaceutical compositions containing them
GB8611807D0 (en) Envelope
NZ223217A (en) Hiv-2 envelope peptides and compositions containing them
IL88673A0 (en) N-hydroxy-5-phenyl-2-furancarboxi-midamides,and pharmaceutical compositions containing them
GB2195979B (en) Improved envelope
IL85524A0 (en) Heterocyclyl-2-propyn-1-amines and pharmaceutical compositions containing same
IL82780A0 (en) Peptides,their manufacture and pharmaceutical compositions containing them